Original Article
/ VOLUME 8, ISSUE 3, MAY 2026
Seroprotection after a Standard Three-Dose Hepatitis B Vaccination Series in Immune-Mediated Rheumatic Diseases: A Retrospective Observational Study
Hepatitis B infection remains a major global public health burden. Hepatitis B virus (HBV) is a leading cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma, and contributes substantially to liver-related morbidit [...] Read More